Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Kariminejad - |
RCV001813941 | SCV001755217 | pathogenic | Abnormality of the musculature | 2021-07-10 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV000003395 | SCV002578934 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 2022-03-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003231073 | SCV003929963 | pathogenic | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Also known as p.Q164X; This variant is associated with the following publications: (PMID: 25525159, 31311558, 12369018, 33772059) |
Baylor Genetics | RCV000003395 | SCV004204081 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003764521 | SCV004570141 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2K; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1; Walker-Warburg congenital muscular dystrophy | 2023-03-07 | criteria provided, single submitter | clinical testing | The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 3239). This premature translational stop signal has been observed in individual(s) with Walker-Warburg syndrome (PMID: 12369018, 31311558). This sequence change creates a premature translational stop signal (p.Gln303*) in the POMT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POMT1 are known to be pathogenic (PMID: 12369018, 15637732, 16575835). |
OMIM | RCV000003395 | SCV000023553 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 2002-11-01 | no assertion criteria provided | literature only |